Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

DE:2QV Stock Latest News

Company AnnouncementsChemomab Restructures Into U.S. Parent Ahead of Merger With Scipher3d agoCMMB

Company AnnouncementsChemomab Tightens Share Structure in U.S. Redomiciliation Ahead of Scipher Merger2w ago6K CMMB
Company AnnouncementsChemomab Refines Share Structure in Domestication Deal Ahead of Scipher Merger1M ago6K CMMB
Company AnnouncementsChemomab Therapeutics Files Q2 2026 Results and Updates SEC Registrations2M ago6K CMMB
Company AnnouncementsChemomab Therapeutics and Scipher Medicine to Merge in AI‑Driven Rheumatoid Arthritis Play3M ago6K CMMB

Chemomab Therapeutics, Scipher Medicine announce merger agreement

The FlyChemomab Therapeutics, Scipher Medicine announce merger agreement3M agoCMMB

Company AnnouncementsChemomab Therapeutics Revamps Board and Committees With New Independent Director5M ago6K CMMB

RatingsOkunewitch Reiterates Buy on Emerging Nebokitug Data and Solid Cash Runway; Price Target Maintained at $55M agoCMMB

Company AnnouncementsChemomab Highlights New Nebokitug Data in PSC as Q1 2026 Update Underscores PSC–IBD Potential5M ago6K CMMB
Company AnnouncementsChemomab Shareholders Approve Governance Resolutions and Capital Increase at May 5 Meeting6M ago6K CMMB
Company AnnouncementsChemomab Adjourns April 28 Shareholder Meeting to May 5 After Quorum Shortfall6M ago6K CMMB
Company AnnouncementsChemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance Matters7M ago6K CMMB

Chemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data

Company AnnouncementsChemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data7M ago6K CMMB

The FlyChemomab Therapeutics sees cash runway through 1Q277M agoCMMB

The FlyChemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year7M agoCMMB

The FlyChemomab Therapeutics announces results of its Phase 2 SPRING trial11M agoCMMB
Company AnnouncementsChemomab Therapeutics Advances PSC Treatment with Phase 3 Trial11M agoCMMB
Company AnnouncementsChemomab Therapeutics Advances Nebokitug Phase 3 Trial with Regulatory Support11M ago6K CMMB
The FlyChemomab Therapeutics reports Q3 EPS (0.4c) vs (1c) last year11M agoCMMB

Chemomab announces presentations at AASLD 2025 on nebokitug data

The FlyChemomab announces presentations at AASLD 2025 on nebokitug data12M agoCMMB

Pre-EarningsCMMB Earnings this Week: How Will it Perform?12M agoCMMB

Company AnnouncementsChemomab Therapeutics Advances Phase 3 Plans for Nebokitug1y agoCMMB